DIGP News Alert Digipath (DIGP) 0.0530 12/25/2014 02:06:27

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Digipath (DIGP) 0.0530 $DIGP

DigiPath CEO Issues Shareholder Update Letter
PR Newswire - Thu Dec 18, 10:26AM CST
DigiPath, Inc. (OTCBB and OTCQB: DIGP), an independent cannabis testing, media, digital pathology, and education firm, today posted on the company's website a letter from its Chief Executive Officer to its shareholders describing the state of its business.

DigiPath CEO Todd Denkin Shares Cannabis Diversification Move on iHeart Business Talk Radio December 11th, 2014
Marketwired - Thu Dec 11, 6:15AM CST
DigiPath, Inc. (OTCBB: DIGP) (OTCQB: DIGP), an independent cannabis testing, broadcast media, digital pathology, and education firm, CEO and President Todd Denkin discusses DigiPath's growth in the burgeoning cannabis industry with Michael Yorba on Clear Channel-iHeart Business Talk Radio's "The Traders Network" Show.

AdLarge Media Signs Exclusive National Advertising Sales Agreement To Represent "The National Marijuana News" Radio Program
PR Newswire - Wed Dec 10, 10:05AM CST
AdLarge Media has announced an agreement for exclusive, national advertising sales representation of The National Marijuana News (TNMNews), the unbiased news/talk program focused on the political, economic, medical, and social implications of the rapidly evolving marijuana industry.

TNMNews.com Examines Effects of Filmmakers, Activists, and Entrepreneurs on Marijuana Reform
PR Newswire - Wed Dec 03, 7:50AM CST
The National Marijuana News Corp., a wholly owned subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), has just released its sixth unbiased cannabis news show. Hosted by Todd Denkin and Jen Gentile, the program explores the ways filmmakers, activists, and entrepreneurs shape marijuana public opinion and policy. The show is now available at www.tnmnews.com and at www.Live365.com.

DigiPath, Inc., Reports Its 2014 Annual Results
PR Newswire - Wed Nov 26, 8:00AM CST
DigiPath, Inc. (OTCBB and OTCQB: DIGP), an independent cannabis testing, broadcast media, digital pathology, and education firm, today issued its financial report for its fiscal year ended September 30, 2014.

Cannabis for Pennies per Gram and Lobbying for Patient Safety Now on DigiPath's TNMNews.com
PR Newswire - Thu Nov 13, 5:00AM CST
The National Marijuana News, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), has just released its fifth unbiased cannabis news segment, which focuses on radical changes on the horizon for the cannabis industry. Interview guests include Taylor West, Deputy Director for the National Cannabis Industry Association (NCIA), and one of the most recognized personalities in the marijuana industry, Cheryl Shuman. The audio segments are available at www.tnmnews.com.

Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 68.08 (+1.82)

DigiPath announces grant of Nevada State's approval for new medical Cannabis testing lab in Las Vegas
M2 - Fri Nov 07, 6:27AM CST
Cannabis testing firm DigiPath (OTCBB IGP)(OTCQB IGP) revealed on Thursday the receipt of approval from the State of Nevada to open and operate a new cannabis testing laboratory in Las Vegas, Nevada.

DigiPath Receives Nevada State Approval for Cannabis Testing Lab in Las Vegas
PR Newswire - Thu Nov 06, 8:00AM CST
DigiPath, Inc. (OTCBB and OTCQB: DIGP), an independent cannabis testing and media firm, announced today that it has received approval from the State of Nevada for its DigiPath Labs subsidiary to open and operate a cannabis testing laboratory at 6450 Cameron Street, Suite 113, in Las Vegas, Nevada.

Cannabis Stocks Move Lower as Mid-terms Approach
ACCESSWIRE - Tue Nov 04, 8:02AM CST
Whitefish, MT / November 4, 2014 / Cannabis stocks moved lower last week and early this week, according to data from the Marijuana Index(TM). Top gainers included Endexx Corporation (OTC: EDXC), which is trading up more than 35% since last Monday, despite having no recent press releases. Industry bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) were trading largely even for the week, as of mid-day trading on Monday.
GWPH: 68.08 (+1.82), MGW.VN: 0.040 (unch)

DigiPath Explores Cannabis in Midterm Election Politics in New TNMNews Segment
PR Newswire - Thu Oct 30, 5:00AM CDT
The National Marijuana News, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), has just released its special midterm election edition of its popular, unbiased cannabis news program on www.TNMNews.com.

DigiPath PathScope hardware to be used at Kadisco General Hospital in Ethiopia to help doctors diagnose cervical and breast cancers, HIV/AIDS and STIs
M2 - Fri Oct 24, 7:55AM CDT
Provider of digital pathology solutions DigiPath Corp, a subsidiary of DigiPath Inc (OTCBB and OTCQB: DIGP), announced on Friday that its PathScope solution has been selected to to improve patient care in Ethiopia.

DigiPath Corp Expands Global Reach, Provides Pathology Solutions to USAID in Ethiopia
PR Newswire - Fri Oct 24, 5:00AM CDT
DigiPath Corp, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and other services to the cannabis industry, is expanding abroad to bring its cutting-edge PathScope(TM) to improve patient care in Ethiopia. DigiPath's PathScope(TM) hardware will be used by Kadisco General Hospital in Ethiopia via a grant funded by the HANSHEP Health Enterprise Fund and implemented by USAID's SHOPS project.

Cannabis Stocks Move Lower After Poor Data at GW Pharma
ACCESSWIRE - Mon Oct 20, 9:33AM CDT
Whitefish, MT / ACCESSWIRE / October 20, 2014 / Cannabis stocks moved largely lower over the past week, led by a 12% drop in GW Pharmaceuticals plc (NASDAQ: GWPH). The company's Phase IIA study of GWP42003 - a CBD-based compound - for ulcerative colitis failed to meet the primary endpoint of disease remission. While second endpoints were promising, the drug also showed poor toleration among patients with a number withdrawing.
GWPH: 68.08 (+1.82)

DigiPath Corp Collaborates with Penn State College of Engineering on Product Design Improvement Project
PR Newswire - Thu Oct 16, 5:00AM CDT
DigiPath Corp, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider, is sponsoring a senior capstone design project through The Learning Factory at the Penn State College of Engineering, over the duration of the Fall 2014 semester.

Special Edition of The National Marijuana News Features an Exclusive Interview with High Times Magazine Cofounder Michael Kennedy
PR Newswire - Tue Oct 14, 5:00AM CDT
Starting today, a special edition of The National Marijuana News is available at www.TNMNews.com. This episode features former Howard Stern Show writer/personality and current TNMNews East Coast Correspondent Jackie Martling's interview with High Times Magazine cofounder and general counsel Michael Kennedy. The show will also be available at Live365.com.

DigiPath Inc. Cofounder Todd Denkin Takes Over as CEO and President
PR Newswire - Mon Oct 06, 8:30AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and related services, has appointed its cofounder Todd Denkin CEO and president. Denkin is taking the reins from Joe Tanner, who is staying onboard as a consultant, but is leaving the senior executive position to spend more time with his family.

DigiPath, Inc., Completes Management Restructuring with Three Senior Appointments
PR Newswire - Mon Aug 25, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into cannabis testing and other services to the cannabis industry, announced three top-level appointments today, completing its management restructuring plan.

Global Digital Pathology Market 2014-2018 - Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage
M2 - Tue Aug 19, 5:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ggtzl3/digital_pathology) has announced the addition of the "Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Global Forecasts & Trends to 2018" report to their offering. This report categorizes the global digital pathology market into different products and applications. Scanners accounted for the largest share of the digital pathology products market, followed by analytics. The analytics market is expected to grow at the highest CAGR of 12.4% from 2013 to 2018. The high growth can be attributed to the growing importance of image analysis software that is increasingly being used to understand cancer complexity and the drive for personalized medicine, among others. This report covers the definition, description, and forecast of the global market in terms of products, applications, and geographies. The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The dominance of the North American market can be attributed to reasons such as the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, the Asian market is expected to experience the highest growth in the market. The high growth in the Asian region can be attributed to the rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the uses to improve the quality of cancer diagnosis. Some of the prominent players in the global market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.). Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Digital Pathology: Rationale for Adoption 5 Global Digital Pathology Market, By Product 6 Global Digital Pathology Market, By Application 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles - 3dhistech Ltd. - Apollo Pacs, Inc. - Aurora Interactive Ltd. - Corista LLC - Definiens AG - Digipath, Inc. - Hamamatsu Photonics K.K. - Huron Technologies International, Inc. - Indica Labs, Inc. - Kanteron Systems - Leica Biosystems, Gmbh - Ligolab, LLC - Mikroscan Technologies, Inc. - Nikon Instruments, Inc. - Objective Pathology Services, Ltd. - Omnyx, LLC - Pathxl, Ltd. - Pixcelldata, Ltd. - Sunquest Information Systems, Inc. - Ventana Medical Systems, Inc. - Visiopharm - Xifin, Inc. For more information visit http://www.researchandmarkets.com/research/gg..._pathology

DigiPath's Dr. Cindy Orser Speaks on the Importance of Adopting Cannabis Standards August 14, 2014
PR Newswire - Tue Aug 05, 8:00AM CDT
DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into the cannabis testing and education markets, announced today that Cindy Orser, Ph.D. will lead an introductory webinar on the importance of standards in the cannabis industry on Thursday, August 14, 2014. The key issue of adopting standards is the second in a five-week series of webinars collectively titled: "Cannabis 2.0: Making It in the Emerging Marijuana Industry," which begins on August 7th.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 41

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 124

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 97

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 73

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 72

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 117

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 111

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 83

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading

Top 5 Most Recently Viewed Articles

Fluor Corporation Investors Alert: Join the Class Action Now

Updated Category News Views 153

Fluor Corporation Class Action Overview The Portnoy Law Firm has issued an important announcement regarding Fluor Corporation's recent class action lawsuit. Investors who purchased securities of Fluor during a specified period are encouraged to participate. Details of the Class Action This class action is targeting investors who acquired Fluor Corporation shares from...

Continue Reading
Maravai LifeSciences Investors: Are You Affected by Recent Issues?

Updated Category News Views 141

Maravai LifeSciences Holdings, Inc. Overview Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) has quickly become a pivotal player in the biopharmaceutical sector. Their innovative approach and dedication to improving scientific methods have attracted attention from investors and stakeholders alike. However, recent events have thrown some uncertainty into the landscape...

Continue Reading
Gesa Credit Union Acquires Willamette Valley Bank

Updated Category News Views 73

Community Banking Shake-Up in the Pacific Northwest Ah, mergers and acquisitions—they’re like spices in the economic salsa. Today's special? Gesa Credit Union, one of Washington’s powerhouses, deciding to acquire Willamette Valley Bank. Nothing gets the business blood pumping like a good ol' fashioned acquisition. The Financial Backdrop This deal isn't some casual...

Continue Reading
Market Uncertainty Eases as Economic Data Floods In

Updated Category News Views 181

Market Uncertainty Eases as Economic Data Floods In The US government shutdown has come to an end. However, as soon as the funding bill was signed, the markets shifted their focus toward the substantial economic data that has been delayed for over six weeks. This hiatus lasted for forty-three days without any federal reporting, resulting in a significant gap in available...

Continue Reading
AIM Congress 2026: Shaping Future Investment Pathways

Updated Category News Views 510

Exciting News About AIM Congress 2026 The Organizing Committee of AIM Congress, the foremost investment platform globally, has announced the launch of its 15th edition, centered around the compelling theme: Reshaping Global Prosperity: Unlocking New Investment Pathways Towards a Sustainable and Inclusive Future. This prestigious event is set to take place in April 2026 at...

Continue Reading